Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 2/20 | 0.60 |
| ▸ | MMP1 | P03956 | 1/20 | 0.60 |
| ▸ | MMP2 | P08253 | 1/20 | 0.60 |
| ▸ | MMP9 | P14780 | 1/20 | 0.60 |
| ▸ | MMP8 | P22894 | 1/20 | 0.60 |
| ▸ | MMP13 | P45452 | 1/20 | 0.60 |
| ▸ | MEP1B | Q16820 | 5/20 | 0.52 |
| ▸ | MEP1A | Q16819 | 1/20 | 0.52 |
| ▸ | CNR2 | P34972 | 2/20 | 0.51 |
| ▸ | RORC | P51449 | 7/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | RORA | P35398 | 2/20 | 0.47 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.47 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5281753 | 0.85 | CNR2 (0.55) | CA2CNR2RORCRORANR1H2 | |
| SCHEMBL8039632 | 0.84 | MMP3 (0.57) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL8041132 | 0.83 | BMP1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL2845552 | 0.83 | MEP1B (0.68) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL10478607 | 0.83 | RORC (0.61) | CA2CNR2RORCRORANR1H2 | |
| SCHEMBL7686664 | 0.82 | MMP2 (0.57) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL6411529 | 0.81 | BMP1 (0.53) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL31165765 | 0.81 | CNR2 (0.51) | CNR2RORCKMT2ARORANR1H2 | |
| SCHEMBL8037741 | 0.80 | CNR2 (0.59) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL8041116 | 0.80 | MMP2 (0.55) | CA1CA2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6228988-B1 | SOLID PHASE SYNTHESIS BY FORMING MIXTURE OF LIQUID AND SOLID PHASE REACTION PRODUCT, CLEAVING PRODUCT FROM SOLID PHASE, DEPROTECTING THE NITROGEN IF NECESSARY, SEPARATING LIQUID AND SOLID REACTION PHASE, AND RECOVERING PRODUCT | BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) | 2001-05-08 | — | — | US | disclosed |
| US-6093798-A | SOLID PHASE REACTION PRODUCT OF HYDROXYLAMINE OR PROTECTED HYDROXYLAMINE GROUPS LINKED TO INSOLUBLE SUPPORT THROUGH ACID OR PHOTOLYSIS CLEAVABLE LINKER; FOR PRODUCTION OF ENZYME INHIBITORS OF ZINC METALLOPROTEINASE ENZYMES | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2000-07-25 | — | — | US | disclosed |
| US-5932695-A | SOLID PHASE BIOSYNTHESIS; COMBINATORIAL LIBRARIES | BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) | 1999-08-03 | — | — | US | disclosed |
| EP-0811019-B1 | SYNTHESIS OF HYDROXAMIC ACID DERIVATIVES | BRITISH BIOTECH PHARM (GB) | 1999-04-07 | — | — | EP | disclosed |
| EP-0811019-A1 | SYNTHESIS OF HYDROXAMIC ACID DERIVATIVES | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1997-12-10 | — | — | EP | disclosed |
| WO-1996026223-A1 | SYNTHESIS OF HYDROXAMIC ACID DERIVATIVES | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1996-08-29 | — | — | WO | disclosed |